Free Trial

OS Therapies (OSTX) SEC Filings & 10K Form

OS Therapies logo
$1.53 -0.04 (-2.55%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$1.53 0.00 (0.00%)
As of 04/17/2025 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent OS Therapies SEC Filings

DateFilerForm TypeView
04/16/2025
1:51 PM
Ayala Pharmaceuticals, Inc. (Filed by)
OS Therapies (Subject)
Form SCHEDULE 13G
04/11/2025
8:45 PM
Auerbach Shalom (Reporting)
Einodmil LLC (Reporting)
OS Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
4:29 PM
OS Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
8:01 PM
OS Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
8:01 PM
OS Therapies (Filer)
Form DEFA14A
03/31/2025
3:39 PM
OS Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:30 PM
Auerbach Shalom (Filed by)
OS Therapies (Subject)
Form SCHEDULE 13D/A
02/28/2025
5:03 PM
OS Therapies (Issuer)
Romness Paul A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:05 PM
OS Therapies (Filer)
Form DEF 14A
02/28/2025
3:05 PM
Auerbach Shalom (Filed by)
OS Therapies (Subject)
Form SCHEDULE 13D/A
02/28/2025
3:05 PM
Auerbach Shalom (Reporting)
Einodmil LLC (Reporting)
OS Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:00 PM
Auerbach Shalom (Reporting)
Einodmil LLC (Reporting)
OS Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
11:15 PM
OS Therapies (Filer)
Form EFFECT
02/12/2025
7:02 AM
OS Therapies (Subject)
SATTERFIELD THOMAS A JR (Filed by)
Form SCHEDULE 13G/A
02/07/2025
4:23 PM
OS Therapies (Filer)
Form PRE 14A
02/06/2025
5:17 PM
Galzahr Karim (Reporting)
OS Therapies (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/31/2025
3:22 PM
OS Therapies (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/29/2025
8:27 AM
OS Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2025
6:47 PM
Auerbach Shalom (Filed by)
OS Therapies (Subject)
Form SCHEDULE 13D
01/17/2025
6:00 PM
Auerbach Shalom (Reporting)
Einodmil LLC (Reporting)
OS Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
3:52 PM
OS Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
7:25 PM
Auerbach Shalom (Reporting)
Einodmil LLC (Reporting)
OS Therapies (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/14/2025
7:26 PM
Auerbach Shalom (Reporting)
Einodmil LLC (Reporting)
OS Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:56 PM
OS Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
11:15 PM
OS Therapies (Filer)
Form EFFECT
01/13/2025
8:26 AM
OS Therapies (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/03/2025
4:27 PM
OS Therapies (Filer)
Form S-1/A
12/30/2024
4:28 PM
OS Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
8:14 AM
OS Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
4:11 PM
OS Therapies (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/01/2024
4:00 PM
OS Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
3:12 PM
Jarry Olivier Roger (Reporting)
OS Therapies (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/28/2024
3:30 PM
OS Therapies (Subject)
SATTERFIELD THOMAS A JR (Filed by)
Form SC 13G
08/22/2024
3:05 PM
OS Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
3:25 PM
OS Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2024
3:47 PM
Ciccio John (Reporting)
OS Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:47 PM
OS Therapies (Issuer)
Search Theodore F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
4:07 PM
OS Therapies (Filer)
Form 424B4
08/01/2024
8:11 AM
Ciccio John (Reporting)
OS Therapies (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/01/2024
8:13 AM
GODDARD COLIN (Reporting)
OS Therapies (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/01/2024
8:15 AM
OS Therapies (Issuer)
PETIT ROBERT (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
BREAKING: Trump Bans NVIDIA Chips to China (Ad)

On April 16th, 2025, President Trump banned Nvidia from selling its most advanced semiconductors to China. That brings the U.S. and China closer to war than at any time since the Korean War ended in 1953.

There's a good chance you own at least one of these through a brokerage account, mutual fund, 401K,
08/01/2024
8:16 AM
OS Therapies (Issuer)
Romness Paul A. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/01/2024
8:19 AM
OS Therapies (Issuer)
Search Theodore F. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/01/2024
8:08 AM
Acevedo Christopher P. (Reporting)
OS Therapies (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/01/2024
8:10 AM
Borg Joacim (Reporting)
OS Therapies (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/31/2024
11:15 PM
OS Therapies (Filer)
Form EFFECT
07/30/2024
1:41 PM
OS Therapies (Filer)
Form CERT
07/30/2024
1:29 PM
OS Therapies (Filer)
Form 8-A12B
06/13/2024
1:05 PM
OS Therapies (Filer)
Form S-1/A
06/07/2024
2:51 PM
OS Therapies (Filer)
Form S-1/A
06/03/2024
11:52 AM
OS Therapies (Filer)
Form RW
06/03/2024
10:30 AM
OS Therapies (Filer)
Form RW
05/30/2024
4:08 PM
OS Therapies (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/20/2024
2:43 PM
OS Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/20/2024
2:32 PM
OS Therapies (Filer)
Form SP 15D2
05/15/2024
3:36 PM
OS Therapies (Filer)
Form NT 10-Q
05/13/2024
4:14 PM
OS Therapies (Filer)
Form POS AM
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:OSTX) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners